Jonathan Wolleben Analyst Performance

Managing Director at Citizens Jmp

Jonathan Wolleben is a stock analyst at Citizens Jmp focused in the medical sector, covering 27 publicly traded companies. Over the past year, Jonathan Wolleben has issued 74 stock ratings, including buy and hold recommendations. While full access to Jonathan Wolleben's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jonathan Wolleben's coverage history, rating activity, and performance tendencies â€” helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 113 Last 5 Years
Buy Recommendations: 96.30% 104 Buy Ratings
Companies Covered: 27 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	96.3%	104 ratings
Hold	3.7%	4 ratings
Sell	0.0%	0 ratings

Out of 108 total stock ratings issued by Jonathan Wolleben at Citizens Jmp, the majority (96.3%) have been Buy recommendations, followed by 3.7% Hold.

Best & Worst Calls

Best Call
0000.0%
MBX
Apr 2025
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
000.0%
PRQR
Sep 2021
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	100.0% of companies on NASDAQ	27 companies

Jonathan Wolleben, an analyst at Citizens Jmp, currently covers 27 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 26 companies	96.3%
	Manufacturing 1 company	3.7%

Jonathan Wolleben of Citizens Jmp specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 17 companies	63.0%
MED - DRUGS 8 companies	29.6%
PHARMACEUTICAL PREPARATIONS 2 companies	7.4%

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
SPRB Spruce Biosciences	5/14/2026	Lower Price Target	$57.14	$150.00	Market Outperform
ALT Altimmune	5/14/2026	Lower Price Target	$2.97	$11.00	Market Outperform
PHVS Pharvaris	5/13/2026	Lower Price Target	$32.08	$74.00	Market Outperform
KLRS Kalaris Therapeutics	5/13/2026	Lower Price Target	$4.63	$25.00	Market Outperform
IRD Opus Genetics	5/13/2026	Lower Price Target	$5.05	$11.00	Market Outperform
MBX MBX Biosciences	5/12/2026	Boost Price Target	$40.08	$86.00	Market Outperform
CRNX Crinetics Pharmaceuticals	5/8/2026	Lower Price Target	$38.03	$95.00	Market Outperform
BCRX BioCryst Pharmaceuticals	5/7/2026	Boost Price Target	$8.65	$28.00	Market Outperform
PTGX Protagonist Therapeutics	5/6/2026	Boost Price Target	$101.13	$137.00	Market Outperform
BMEA Biomea Fusion	5/5/2026	Initiated Coverage	$1.48	$9.00	Market Outperform
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
DBVT DBV Technologies	5/1/2026	Boost Price Target	$19.93	$55.00	Market Outperform
KALV KalVista Pharmaceuticals	4/29/2026	Downgrade	$26.66		Hold
IRD Opus Genetics	4/28/2026	Initiated Coverage	$5.12	$12.00	Market Perform
CRNX Crinetics Pharmaceuticals	4/28/2026	Boost Price Target	$38.62	$97.00	Market Outperform
MIRM Mirum Pharmaceuticals	4/21/2026	Reiterated Rating	$94.25	$132.00	Market Outperform
DBVT DBV Technologies	3/27/2026	Boost Price Target	$20.75	$47.00	Market Outperform
KALV KalVista Pharmaceuticals	3/26/2026	Lower Price Target	$16.83	$28.00	Market Outperform
RYTM Rhythm Pharmaceuticals	3/17/2026	Lower Price Target	$90.07	$152.00	Market Outperform
SPRB Spruce Biosciences	3/10/2026	Lower Price Target	$62.11	$170.00	Market Outperform
CRNX Crinetics Pharmaceuticals	3/2/2026	Lower Price Target	$41.10	$96.00	Market Outperform
RYTM Rhythm Pharmaceuticals	2/27/2026	Boost Price Target	$98.07	$176.00	Market Outperform
GPCR Structure Therapeutics	2/27/2026	Lower Price Target	$64.75	$113.00	Market Outperform
PTGX Protagonist Therapeutics	2/26/2026	Boost Price Target	$86.85	$112.00	Market Outperform
MIRM Mirum Pharmaceuticals	2/26/2026	Lower Price Target	$92.21	$132.00	Market Outperform
SION Sionna Therapeutics	2/24/2026	Initiated Coverage	$36.10	$63.00	Market Outperform
QNCX Quince Therapeutics	1/30/2026	Downgrade	$0.27		Market Perform
MDGL Madrigal Pharmaceuticals	1/20/2026	Boost Price Target	$501.68	$745.00	Market Outperform
CRNX Crinetics Pharmaceuticals	1/8/2026	Lower Price Target	$53.34	$105.00	Market Outperform
MIRM Mirum Pharmaceuticals	12/19/2025	Boost Price Target	$70.28	$140.00	Market Outperform
DBVT DBV Technologies	12/17/2025	Boost Price Target	$17.98	$45.00	Market Outperform
GPCR Structure Therapeutics	12/12/2025	Boost Price Target	$67.44	$120.00	Market Outperform
RYTM Rhythm Pharmaceuticals	12/12/2025	Boost Price Target	$117.62	$167.00	Market Outperform
SGMT Sagimet Biosciences	11/14/2025	Boost Price Target	$7.61	$35.00	Market Outperform
SVRA Savara	11/13/2025	Lower Price Target	$4.12	$10.00	Market Outperform
SPRB Spruce Biosciences	11/11/2025	Set Price Target	$115.61	$259.00
SPRB Spruce Biosciences	11/11/2025	Boost Price Target	$115.61	$259.00	Market Outperform
KALV KalVista Pharmaceuticals	11/11/2025	Lower Price Target	$10.89	$28.00	Market Outperform
ALT Altimmune	11/7/2025	Lower Price Target	$3.94	$14.00	Market Outperform
CRNX Crinetics Pharmaceuticals	11/7/2025	Lower Price Target	$43.49	$108.00	Market Outperform
PTGX Protagonist Therapeutics	11/7/2025	Boost Price Target	$79.63	$102.00	Market Outperform
Your book is inside (Ad) The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today. Download your copy now.
MIRM Mirum Pharmaceuticals	11/5/2025	Set Price Target	$70.97	$95.00
MDGL Madrigal Pharmaceuticals	11/5/2025	Set Price Target	$444.64	$527.00
BCRX BioCryst Pharmaceuticals	11/5/2025	Lower Price Target	$6.76	$25.00	Market Outperform
MDGL Madrigal Pharmaceuticals	11/5/2025	Boost Price Target	$444.64	$527.00	Market Outperform
MIRM Mirum Pharmaceuticals	11/5/2025	Boost Price Target	$70.97	$95.00	Market Outperform
KLRS Kalaris Therapeutics	11/3/2025	Initiated Coverage	$5.03	$20.00	Market Outperform
SPRB Spruce Biosciences	10/28/2025	Set Price Target	$123.02	$254.00	Market Outperform
SVRA Savara	10/23/2025	Boost Price Target	$4.11	$11.00	Market Outperform
BCRX BioCryst Pharmaceuticals	10/15/2025	Boost Price Target	$6.42	$27.00	Market Outperform
ATXS Astria Therapeutics	10/15/2025	Reiterated Rating	$11.61		Market Perform
OCUL Ocular Therapeutix	10/1/2025	Boost Price Target	$11.69	$29.00	Market Outperform
CRNX Crinetics Pharmaceuticals	9/26/2025	Boost Price Target	$35.89	$143.00	Market Outperform
RYTM Rhythm Pharmaceuticals	9/25/2025	Boost Price Target	$96.86	$142.00	Market Outperform
KALV KalVista Pharmaceuticals	9/12/2025	Boost Price Target	$14.81	$28.00	Market Outperform
MDGL Madrigal Pharmaceuticals	8/20/2025	Boost Price Target	$379.55	$485.00	Market Outperform
LRMR Larimar Therapeutics	8/15/2025	Lower Price Target	$4.30	$18.00	Market Outperform
PHVS Pharvaris	8/13/2025	Lower Price Target	$21.47	$52.00	Market Outperform
ATXS Astria Therapeutics	8/13/2025	Boost Price Target	$6.88	$26.00	Market Outperform
QNCX Quince Therapeutics	8/12/2025	Lower Price Target	$15.70	$80.00	Market Outperform
CRNX Crinetics Pharmaceuticals	8/11/2025	Lower Price Target	$26.85	$86.00	Market Outperform
GPCR Structure Therapeutics	8/7/2025	Lower Price Target	$16.31	$87.00	Market Outperform
PTGX Protagonist Therapeutics	8/7/2025	Boost Price Target	$53.42	$69.00	Market Outperform
MIRM Mirum Pharmaceuticals	8/7/2025	Set Price Target	$59.41	$81.00	Market Outperform
RYTM Rhythm Pharmaceuticals	8/6/2025	Boost Price Target	$89.85	$135.00	Market Outperform
ALT Altimmune	7/10/2025	Lower Price Target	$4.21	$15.00	Market Outperform
KALV KalVista Pharmaceuticals	7/8/2025	Boost Price Target	$15.69	$27.00	Market Outperform
PRQR ProQR Therapeutics	6/27/2025	Reiterated Rating	$2.16	$8.00	Market Outperform
RYTM Rhythm Pharmaceuticals	6/26/2025	Reiterated Rating	$62.19	$84.00	Market Outperform
DBVT DBV Technologies	6/26/2025	Reiterated Rating	$9.06	$21.00	Market Outperform
SKYE Skye Bioscience	6/24/2025	Reiterated Rating	$3.16	$15.00	Market Outperform
GPCR Structure Therapeutics	6/23/2025	Reiterated Rating	$21.73	$89.00	Market Outperform
DBVT DBV Technologies	5/27/2025	Boost Price Target	$8.41	$21.00	Market Outperform
AURA Aura Biosciences	5/23/2025	Reiterated Rating	$5.91	$19.00	Market Outperform
CLSD Clearside Biomedical	5/16/2025	Reiterated Rating	$13.23	$75.00	Market Outperform
MIRM Mirum Pharmaceuticals	5/9/2025	Boost Price Target	$45.07	$76.00	Market Outperform
MDGL Madrigal Pharmaceuticals	4/24/2025	Reiterated Rating	$308.00	$443.00	Market Outperform
MBX MBX Biosciences	4/10/2025	Initiated Coverage	$6.12	$38.00	Market Outperform
AURA Aura Biosciences	3/26/2025	Set Price Target	$5.25	$19.00
PTGX Protagonist Therapeutics	2/7/2025	Reiterated Rating	$39.61	$58.00	Market Outperform
ATXS Astria Therapeutics	1/31/2025	Initiated Coverage	$7.49	$26.00	Outperform
KALV KalVista Pharmaceuticals	1/31/2025	Initiated Coverage	$8.77	$19.00	Outperform
PHVS Pharvaris	1/31/2025	Boost Price Target	$18.06	$55.00	Market Outperform
BCRX BioCryst Pharmaceuticals	1/31/2025	Reiterated Rating	$7.96	$18.00	Market Outperform
DBVT DBV Technologies	1/10/2025	Reiterated Rating	$4.14	$10.00	Market Outperform
MDGL Madrigal Pharmaceuticals	1/10/2025	Reiterated Rating	$330.62	$427.00	Market Outperform

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.